VCN logo

Vicenne S.ACBSE:VCN Stock Report

Market Cap د.م3.9b
Share Price
د.م380.00
د.م1.3k
70.8% undervalued intrinsic discount
1Yn/a
7D3.8%
1D
Portfolio Value
View

Vicenne S.A

CBSE:VCN Stock Report

Market Cap: د.م3.9b

Vicenne (VCN) Stock Overview

Distributes technology-intensive equipment, solutions, and services to healthcare professionals. More details

VCN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends1/6

Rewards

Risk Analysis

No risks detected for VCN from our risk checks.

VCN Community Fair Values

Create Narrative

See what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.

Vicenne S.A Competitors

Price History & Performance

Summary of share price highs, lows and changes for Vicenne
Historical stock prices
Current Share Priceد.م380.00
52 Week Highد.م546.50
52 Week Lowد.م259.55
Beta0
1 Month Change-2.81%
3 Month Change-5.00%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO46.41%

Recent News & Updates

Recent updates

Shareholder Returns

VCNMA HealthcareMA Market
7D3.8%4.1%2.2%
1Yn/a0.7%5.0%

Return vs Industry: Insufficient data to determine how VCN performed against the MA Healthcare industry.

Return vs Market: Insufficient data to determine how VCN performed against the MA Market.

Price Volatility

Is VCN's price volatile compared to industry and market?
VCN volatility
VCN Average Weekly Movement5.4%
Healthcare Industry Average Movement5.1%
Market Average Movement4.9%
10% most volatile stocks in MA Market7.6%
10% least volatile stocks in MA Market3.0%

Stable Share Price: VCN has not had significant price volatility in the past 3 months compared to the MA market.

Volatility Over Time: VCN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004327Adnane Zerhouniwww.vicenne.com

Vicenne S.A distributes technology-intensive equipment, solutions, and services to healthcare professionals. It provides medical equipment, laboratory equipment, and implantable devices. The company engages in the distribution of radiotherapy equipment, such as accelerators; medical imaging, including MRI, scanners, and catheterization rooms; implantable medical devices, including heart valves and cochlear implants; and in vitro diagnostics, which include equipment and reagents for laboratories.

Vicenne S.A Fundamentals Summary

How do Vicenne's earnings and revenue compare to its market cap?
VCN fundamental statistics
Market capد.م3.90b
Earnings (TTM)د.م144.28m
Revenue (TTM)د.م1.08b
27.0x
P/E Ratio
3.6x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VCN income statement (TTM)
Revenueد.م1.08b
Cost of Revenueد.م778.41m
Gross Profitد.م305.25m
Other Expensesد.م160.97m
Earningsد.م144.28m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)14.06
Gross Margin28.17%
Net Profit Margin13.31%
Debt/Equity Ratio17.7%

How did VCN perform over the long term?

See historical performance and comparison

Dividends

2.2%
Current Dividend Yield
n/a
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/21 15:32
End of Day Share Price 2026/06/19 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vicenne S.A is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.